Sign in Register

Fluorometholone (fluorometholone)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

Fluorometholone is a synthetic fluorinated corticosteroid that also is structurally related to progesterone.

USES: This medication is used to treat certain eye conditions due to inflammation or injury. Fluorometholone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids.

Generic name: fluorometholone
Pronunciation: (FLOOR-oh-METH-oh-lone)

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Fluorometholone

Intelligence content is not available yet.

Indications

The following indications are listed for Fluorometholone:

  • Acne Rosacea Keratitis
  • Allergic Conjunctivitis
  • Corneal Abrasion
  • Corneal Ulcer
  • Cyclitis
  • Herpes Zoster Keratitis
  • Iridocyclitis
  • Iritis
  • Ocular Inflammation
  • Post-Op Ocular Inflammation
  • Punctate Epithelial Keratopathy
  • Uveitis

Also known as: Acute Iritis, Allergy Eye Itch, Atopic Conjunctivitis, Corneal Abrasion Injury, Corneal Injury, Itchy Eyes Due To Allergies, Ocular Itching Due To Allergies, Ophthalmic Inflammation, Postoperative Ocular Inflammation, Postoperative Ophthalmic Inflammation, Punctate Keratopathy, Rosacea Keratitis, Ulcerative Keratitis.

Dosing

Fluorometholone and fluorometholone acetate are applied topically to the eye. Care should be taken to avoid contamination of the tip of the dropper or ointment tube.

One drop of the 0.1% or 0.25% ophthalmic suspension (containing fluorometholone) may be instilled into the conjunctival sac of the affected eye(s) 2-4 times daily or 1.3 cm (1/2 inch) of the 0.1% ointment may be applied in the conjunctival sac of the affected eye(s) 1-3 times daily. During the initial 24-48 hours of therapy with fluorometholone 0.1% suspension or ointment, dosage may be increased to 1 drop of suspension or 1.3 cm of ointment every 4 hours. If improvement does not occur within several days, the drug should be discontinued and other therapy begun. The duration of treatment depends on the type and severity of the disease and may range from a few days to several weeks; long-term therapy should be avoided. When the drug is discontinued, dosage should be gradually tapered to avoid exacerbation of the disease.

When fluorometholone acetate is used, 1 to 2 drops of the 0.1% ophthalmic suspension may be instilled into the conjunctival sac 4 times daily. During the initial 24-48 hours of therapy, dosage may be increased to 2 drops every 2 hours. If improvement does not occur after 2 weeks, patients should contact a clinician; fluorometholone acetate therapy should not be discontinued prematurely.

One drop of the suspension containing a fixed combination of fluorometholone and sulfacetamide sodium may be instilled into the lower conjunctival sac 4 times daily. When the suspension containing a fixed combination of fluorometholone acetate and tobramycin is used, 1 or 2 drops may be instilled into the conjunctival sac every 4-6 hours; during the initial 24-48 hours of therapy, dosage may be increased to 1 or 2 drops every 2 hours. Therapy should not be discontinued prematurely.

Patients should initially receive a prescription for 20 mL or less of suspension or 8 g or less of ointment and should be reevaluated by their clinician prior to obtaining a refill.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a 5-digit ZIP code. Searching does not change your profile.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data